Navigation Links
Vical to Present at BIO CEO and Investor Conference
Date:2/5/2008

NEW YORK, Feb. 5 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL) today announced that Vijay Samant, the company's President and Chief Executive Officer, will present a company overview at 3:30 p.m. EST on Monday, February 11, at the Biotechnology Industry Organization (BIO) CEO and Investor Conference (New York - February 11-13).

About Vical

Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Potential applications of the company's DNA delivery technology include DNA vaccines for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The company is developing certain infectious disease vaccines and cancer therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product pipeline and address significant unmet medical needs. Additional information on Vical is available at http://www.vical.com.

This press release contains forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially from those projected. Forward-looking statements include statements about the company's focus, collaborative partners, product candidates, and developmental status. Risks and uncertainties include whether any product candidates will be shown to be safe and efficacious in clinical trials, the timing of clinical trials, whether Vical or its collaborative partners will seek or gain approva
'/>"/>

SOURCE Vical Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Hollywood On the Hill - A Red Carpet Event on Capitol Hill Raises Awareness for Cervical Cancer Prevention and HPV-Related Technologies
2. National Cervical Cancer Coalition (NCCC) State Chapters to Provide Parents With Educational Forum to Discuss Cervical Cancer and HPV Vaccines
3. Independence Blue Cross Delivers Important Reminder to Women during Cervical Cancer Awareness Month
4. National Cervical Cancer Coalition Stresses Importance of Screening and Prevention During January Cervical Health Awareness Month
5. Study determines costs of breast and cervical cancer detection among low-income women
6. GlaxoSmithKline Receives FDA Complete Response Letter for Cervical Cancer Vaccine
7. Vical Expands Clinical Testing of DNA Vaccine Against H5N1 Pandemic Influenza
8. Post-treatment PET scans can reassure cervical cancer patients
9. PET Scans Can Spot Cervical Cancers Return
10. Pill Poses Little Cervical Cancer Risk
11. Study Finds New Version of QIAGENs HPV Test for Developing Countries Could Reduce Risk of Cervical Cancer by More than Half When Combined With Appropriate Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2014)... epidemic of prescription opioid overdose deaths was outlined yesterday ... by leaders of agencies in the U.S. Department of ... health care providers to expand their use of medications ... describes a number of misperceptions that have limited access ... how medications can be used in combination with behavior ...
(Date:4/24/2014)... Dartmouth has been awarded one of 30 grants ... a Lead Academic Participating Site in its new ... are a select groups of investigators charged with distributing ... groups., The NCTN grant system reflects recommendations from a ... operations to achieve four goals:, Faster design, ...
(Date:4/24/2014)... at the University of York reveals that a process ... the nervous system may also play a pivotal role ... team, led by Dr Will Brackenbury, a Medical Research ... has studied how voltage-gated sodium channels assist in the ... the membranes of excitable cells, such as neurons, where ...
(Date:4/23/2014)... Cancer Center researchers say clinical trials for a ... (AML) are very promising. Patients treated with CPX-351, ... daunorubicin, are showing better responses than patients treated ... , "Acute myeloid leukemia is an aggressive blood ... especially in older patients," explained Jeffrey Lancet, M.D., ...
(Date:4/23/2014)... American Society for Radiation Oncology (ASTRO) has issued ... Therapy for Endometrial Cancer: An ASTRO Evidence-Based Guideline," ... in the treatment of endometrial cancer. The guideline,s ... issue of Practical Radiation Oncology (PRO), ... full-length guideline is available as an open-access article ...
Breaking Medicine News(10 mins):Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 2Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 3Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 4Health News:Dartmouth awarded lead role in NCI clinical trials network 2Health News:Dartmouth awarded lead role in NCI clinical trials network 3Health News:Breast cancer replicates brain development process 2Health News:Moffitt Cancer Center's phase 3 study may be game-changer for acute myeloid leukemia 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 3
... ... ... ... ...
... reasonable decisions when they have limited information? ... Manski explores in his new paper, "Vaccination With ... published online by the Proceedings of the ... http://www.pnas.org/content/early/2010/02/05/0915009107.full.pdf+html . "Let,s say you,re a public ...
... changes will be passed anytime soon , THURSDAY, Feb. ... jump-start health care reform by holding a bipartisan summit ... its stated goal Thursday, with Obama asking legislators to ... Republicans responding with calls for scrapping the current effort ...
... ... ... ... ...
... Government Regulation: ... (PRWEB) February ... some of the stand-out questions include:, , ,   What ... standards impacted by the convergence of media and conflation of traditional media roles? ...
... , ... ... ... ...
Cached Medicine News:Health News:Elements Therapeutic Massage Announces Franchise Expansion Plan for Massachusetts 2Health News:Elements Therapeutic Massage Announces Franchise Expansion Plan for Massachusetts 3Health News:Elements Therapeutic Massage Announces Franchise Expansion Plan for Massachusetts 4Health News:Elements Therapeutic Massage Announces Franchise Expansion Plan for Massachusetts 5Health News:How can policymakers cope with ambiguity? 2Health News:Health Reform Summit Seems to Be Falling Short of Goal 2Health News:Health Reform Summit Seems to Be Falling Short of Goal 3Health News:Health Reform Summit Seems to Be Falling Short of Goal 4Health News:ValueOptions'(R) 'Anxiety Scale': Unemployment, Anxiety Ride Together to New Heights 2Health News:ValueOptions'(R) 'Anxiety Scale': Unemployment, Anxiety Ride Together to New Heights 3Health News:ValueOptions'(R) 'Anxiety Scale': Unemployment, Anxiety Ride Together to New Heights 4Health News:Alan Chapell, President of Chapell & Associates to Deliver Keynote at the Next AdMonsters US Leadership Forum 2Health News:Alan Chapell, President of Chapell & Associates to Deliver Keynote at the Next AdMonsters US Leadership Forum 3Health News:Highmark Inc. Prepares Now for the Diversity Boom Ahead 2Health News:Highmark Inc. Prepares Now for the Diversity Boom Ahead 3Health News:Highmark Inc. Prepares Now for the Diversity Boom Ahead 4
(Date:1/15/2014)... AARP Foundation today announced it has established a relief ... cold weather that has gripped much of the nation. AARP ... so to support these emergency relief efforts AARP and AARP ... mean up to $500,000 in aid. The matching program will ...
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) ... approval condition to the announced tender offer for all of the ... a result of the waiver, the transaction is no longer conditional ... on January 24, 2014 following the currently scheduled expiration time, subject ...
(Date:1/15/2014)... Fla. , Jan. 15, 2014  In an unprecedented effort to ... TB in ambulances and other transport vehicles, an advanced and portable ... rescue personnel for the first time. In order ... with these deadly pathogens, West Palm Beach ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Superbugs No Longer Ride In Rescue Vehicles 2
... July 14, 2011 Boston Scientific Corporation (NYSE: ... for the second quarter ended June 30, 2011 on Thursday, ... will be hosted by Ray Elliott, President and Chief Executive ... Officer. A live webcast of the discussion will ...
... MSA ), the global leader in the development, ... safety, announced today that it will broadcast a second quarter ... July 28, 2011 at 10:00 a.m. Eastern Time.  The call ... parties will have the opportunity to listen to the conference ...
Cached Medicine Technology:Boston Scientific to Webcast Conference Call Discussing Second Quarter 2011 Financial Results 2MSA Schedules Second Quarter Earnings Webcast 2
... Carpal Solution offers relief from CTS pain ... different from other over-the-counter CTS treatments. It ... during sleep, the Carpal Solution gently reshapes ... Tunnel and eliminates hand pain, numbness and ...
... of Hemoglobin S in patient samples. Each ... and 20l of anticoagulated whole blood or ... test kit contains two bottles of phosphate ... and two vials of Sodium Hydrosulfite reagent ...
... tube for the collection, transport and retention ... flow cytometry. The preservative contained in Cyto-Chex ... blood cell cluster of differentiation (CD) markers ... collected in Cyto-Chex BCT are stable at ...
Streck-ONYX-Pack is specially designed for use on Coulter® ONYX Series instruments. Each pack contains diluent and lysing agent. The shelf life is one year from date of manufacture....
Medicine Products: